Ads
-
Related paper
- Histone deacetylase inhibitors: pharmacotherapeutic implications as epigenetic modifier
- Histone Deacetylase Inhibitors: Current Status in Treatment of Leukemia
- The Effects of Vaginal Gestrinone with Histone Deacetylase Inhibitors on Endometriosis-Related Pain and Endometrial Proliferation - A Short Study
- A Mathematical Model on Vorinostat (Histone Deacetylase Inhibitor) in Combination with Radiotherapy
- Effects on Metabolic Parameters of Addition of SGLT‐2 Inhibitors on Patients with Type2 Diabetes Inadequately Controlled with DPP‐IV Inhibitors and Metformin
- Histone Protein Glycation and Diabetes
- Citrullinated Histone H3 Level as a Novel Biomarker in Pediatric Clinical Sepsis
- Comparative Study and Tree Construction of Different Organism Based on Histone Family
- PHARMACO-ECONOMICBENEFITS OF CORRECTION OF ANEMIA WITH CONTINUOUS ERYTHROPOIETIN RECEPTOR ACTIVATOR:HEMODIALYSIS VSHEMODIAFILTRATION
- QUALITY OF LIFE ASSESSMENT AMONG INDIAN DIABETICS ENGAGING AN AYUR-PHARMACO-EPIDEMIOLOGICAL DESIGN